Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Acura Pharmaceuticals Inc (ACUR)  
$0.00 0.00 (36.67%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 65,090,000
Market Cap: 266.87(K)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.000001 - $0.05
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Acura Pharmaceuticals is a drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications. Co. has discovered and developed three proprietary platform technologies which can be used to develop multiple products. Co.'s LIMITx Technology is intended to address the accidental or intentional consumption of multiple tablets. Aversion Technology incorporates gelling ingredients and irritants into tablets to discourage abuse by snorting. Co.'s Impede 1.0 Technology being used in Nexafed Sinus Pressure + Pain contains a proprietary mixture of inactive ingredients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 109
  Page 5 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Brzeczko Albert W VP Technical Affairs - APT   •       –      –    2014-05-19 4 B $1.20 $2,400 D/D 2,000 26,000 2.66     -
   Emigh James F VP Corporate Development   •       –      –    2014-05-16 4 B $1.21 $18,149 D/D 15,000 198,304 2.74     -
   Clemens Peter A Senior VP and CFO   •       –      –    2014-05-16 4/A B $1.21 $3,621 D/D 3,000 275,918 2.66     -
   Wesson Bruce F/ Director   –       •      –    2014-05-16 4 B $1.17 $23,499 D/D 20,000 94,914 2.39     -
   Clemens Peter A Senior VP and CFO   •       –      –    2014-05-16 4 S $1.21 $3,621 D/D (3,000) 275,918     -
   Wesson Bruce F/ Director   –       •      –    2014-05-15 4 B $1.11 $66,970 D/D 60,000 74,914 2.39     -
   Skelly William G Director   –       •      –    2014-05-14 4 S $1.21 $3,509 D/D (2,900) 14,600     -
   Skelly William G Director   –       •      –    2014-05-12 4 S $1.25 $6,250 D/D (5,000) 17,500     -
   Skelly William G Director   –       •      –    2014-05-08 4 S $1.30 $3,250 D/D (2,500) 22,500     -

  109 Records found
  1  2  3  4  5    
  Page 5 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed